Patents by Inventor Peiyuan Wang

Peiyuan Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10072001
    Abstract: Compounds having the following formula (I) and methods of their use and preparation are disclosed:
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: September 11, 2018
    Assignee: Gilead Sciences, Inc.
    Inventors: Zhimin Du, Juan Arnaldo Guerrero, Joshua Aaron Kaplan, John Edward Knox, Jr., Devan Naduthambi, Barton W. Phillips, Chandrasekar Venkataramani, Peiyuan Wang, William J. Watkins, Jeff Zablocki
  • Patent number: 10040781
    Abstract: Compounds having the following formula (I) and methods of their use and preparation are disclosed:
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: August 7, 2018
    Assignee: Gilead Sciences, Inc.
    Inventors: Zhimin Du, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Jr., Jennifer R. Lo, Scott A. Mitchell, Devan Naduthambi, Barton W. Phillips, Chandrasekar Venkataramani, Peiyuan Wang, William J. Watkins, Zhongdong Zhao
  • Publication number: 20180212142
    Abstract: A perpendicular magnetic tunnel junction may include a free layer, a reference layer, and a barrier layer. The barrier layer may be arranged between the free layer and the reference layer. The barrier layer may include a first interface and a second interface. The first interface may face the free layer, and a second interface may face the reference layer. The first interface may not physically correlate with the second interface.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 26, 2018
    Inventors: Chando PARK, Jimmy Jianan KAN, Peiyuan WANG, Seung Hyuk KANG
  • Publication number: 20180145838
    Abstract: Exemplary features pertain to secure communications using Physical Unclonable Function (PUF) devices. Segments of a message to be encrypted are sequentially applied to a PUF device as a series of challenges to obtain a series of responses for generating a sequence of encryption keys, whereby a previous segment of the message is used to obtain a key for encrypting a subsequent segment of the message. The encrypted message is sent to a separate (receiving) device that employs a logical copy of the PUF device for decrypting the message. The logical copy of the PUF may be a lookup table or the like that maps all permissible challenges to corresponding responses for the PUF and may be generated in advance and stored in memory of the receiving device. The data to be encrypted may be further encoded to more fully exercise the PUF to enhance security. Decryption operations are also described.
    Type: Application
    Filed: November 18, 2016
    Publication date: May 24, 2018
    Inventors: Peiyuan Wang, Chando Park, Jimmy Jianan Kan, Seung Hyuk Kang
  • Publication number: 20180061467
    Abstract: A magnetic random access memory (MRAM) array including several bit cells is described. Each of the bit cells may include a perpendicular magnetic tunnel junction (pMTJ) including a reference layer, a barrier layer supporting the reference layer, and a free layer supporting the barrier layer. A spin-hall conductive material layer may support the free layer. A driver may be operable to set a state of at least one of the bit cells using an increased spin-transfer torque (STT) current and a spin-hall effect from the spin-hall conductive material layer. The increased STT current may be driven through the spin-hall conductive material layer and the pMTJ so that a spin current is generated from the reference layer and the spin-hall conductive material layer.
    Type: Application
    Filed: August 25, 2016
    Publication date: March 1, 2018
    Inventors: Jimmy Jianan KAN, Chando PARK, Peiyuan WANG, Sungryul KIM, Seung Hyuk KANG
  • Publication number: 20180044367
    Abstract: Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.
    Type: Application
    Filed: March 28, 2017
    Publication date: February 15, 2018
    Inventors: Byoung-Kwon Chun, Ganapati Reddy Pamulapati, Suguna Rachakonda, Bruce Ross, Michael Joseph Sofia, Peiyuan Wang, Hai-Ren Zhang
  • Patent number: 9882609
    Abstract: Embodiments described herein are related to contactless data communication. Related systems and methods for contactless data communication are disclosed herein. For example, a magnetic field-based contactless transmitter is disclosed that includes a substrate, a pair of dipole coils disposed on the substrate, and a drive circuit electrically coupled to the pair of dipole coils. To transmit data to a magnetic tunnel junction (MTJ) receiver disposed on a second substrate, the drive circuit is configured to drive the pair of dipole coils so as to generate a magnetic field in-plane to the MTJ receiver. Data can be transmitted from the magnetic field-based contactless transmitter to the MTJ receiver using the magnetic field.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: January 30, 2018
    Assignee: QUALCOMM Incorporated
    Inventors: Wenqing Wu, Senthil Kumar Govindaswamy, Raghu Sagar Madala, Peiyuan Wang, Kendrick Hoy Leong Yuen, David Joseph Winston Hansquine
  • Patent number: 9870811
    Abstract: In a particular aspect, an apparatus includes a magnetic random access memory (MRAM) cell including a pair of cross coupled inverters including a first inverter and a second inverter. The first inverter includes a first transistor coupled to a first node and a second transistor coupled to the first node. The second inverter includes a third transistor coupled to a second node and a fourth transistor coupled to the second node. The MRAM cell includes a first magnetic tunnel junction (MTJ) element coupled to the second transistor and a second MTJ element coupled to the fourth transistor. The apparatus further includes a voltage initialization circuit coupled to the MRAM cell. The voltage initialization circuit is configured to substantially equalize voltages of the first node and the second node in response to an initialization signal.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: January 16, 2018
    Assignee: QUALCOMM Incorporated
    Inventors: Peiyuan Wang, Jung Pill Kim, Jimmy Jianan Kan, Chando Park, Seung Kang
  • Publication number: 20180000855
    Abstract: Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
    Type: Application
    Filed: January 20, 2017
    Publication date: January 4, 2018
    Inventors: Jinfa Du, Dhanapalan Nagarathnam, Michael Joseph Sofia, Peiyuan Wang
  • Publication number: 20170365316
    Abstract: In a particular aspect, an apparatus includes a magnetic random access memory (MRAM) cell including a pair of cross coupled inverters including a first inverter and a second inverter. The first inverter includes a first transistor coupled to a first node and a second transistor coupled to the first node. The second inverter includes a third transistor coupled to a second node and a fourth transistor coupled to the second node. The MRAM cell includes a first magnetic tunnel junction (MTJ) element coupled to the second transistor and a second MTJ element coupled to the fourth transistor. The apparatus further includes a voltage initialization circuit coupled to the MRAM cell. The voltage initialization circuit is configured to substantially equalize voltages of the first node and the second node in response to an initialization signal.
    Type: Application
    Filed: June 17, 2016
    Publication date: December 21, 2017
    Inventors: Peiyuan Wang, Jung Pill Kim, Jimmy Jianan Kan, Chando Park, Seung Kang
  • Patent number: 9824735
    Abstract: An apparatus includes a perpendicular magnetic tunnel junction (MTJ) including a free layer. The apparatus includes a spin orbit torque metal layer coupled to the perpendicular MTJ and configured to change a magnetization state of the free layer responsive to flow of a current along the spin orbit torque metal layer. The apparatus includes a random number generator configured to generate a random number at least partially based on a state of the perpendicular MTJ.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: November 21, 2017
    Assignee: QUALCOMM Incorporated
    Inventors: Jimmy Jianan Kan, Chando Park, Peiyuan Wang, Seung Hyuk Kang
  • Publication number: 20170253584
    Abstract: The present invention provides (i) processes for preparing a 2?-deoxy-2?-fluoro-2?-methyl-D-ribonolactone derivatives, (ii) conversion of intermediate lactones to nucleosides with potent anti-HCV activity, and their analogues, and (iii) methods to prepare the anti-HCV nucleosides containing the 2?-deoxy-2?-fluoro-2?-C-methyl-?-D-ribofuranosyl nucleosides from a preformed, preferably naturally-occurring, nucleoside.
    Type: Application
    Filed: February 6, 2017
    Publication date: September 7, 2017
    Applicant: Gilead Pharmasset LLC
    Inventors: Byoung Kwon Chun, Jinfa Du, Suguna Rachakonda, Peiyuan Wang
  • Publication number: 20170174713
    Abstract: Compounds having the following formula (I) and methods of their use and preparation are disclosed:
    Type: Application
    Filed: December 15, 2016
    Publication date: June 22, 2017
    Inventors: Zhimin Du, David Dornan, Juan A. Guerrero, Joshua A. Kaplan, John E. Knox, Devan Naduthambi, Barton W. Phillips, Susanna Y. Stinson, Chandrasekar Venkataramani, Peiyuan Wang, William J. Watkins
  • Patent number: 9637512
    Abstract: Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent 5 RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: May 2, 2017
    Assignee: Gilead Pharmasset LLC
    Inventors: Byoung-Kwon Chun, Ganapati Reddy Pamulapati, Suguna Rachakonda, Bruce Ross, Michael Joseph Sofia, Peiyuan Wang, Hai-Ren Zhang
  • Patent number: 9585906
    Abstract: Disclosed herein are phosphoramidate prodrugs of nucleoside derivatives for the treatment of viral infections in mammals, which is a compound, its stereoisomer, salt (acid or basic addition salt), hydrate, solvate, or crystalline form thereof, represented by the following structure: Also disclosed are methods of treatment, uses, and processes for preparing each of which utilize the compound represented by formula I.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: March 7, 2017
    Assignee: Gilead Pharmasset LLC
    Inventors: Jinfa Du, Dhanapalan Nagarathnam, Michael J. Sofia, Peiyuan Wang
  • Publication number: 20170019153
    Abstract: Embodiments described herein are related to contactless data communication. Related systems and methods for contactless data communication are disclosed herein. For example, a magnetic field-based contactless transmitter is disclosed that includes a substrate, a pair of dipole coils disposed on the substrate, and a drive circuit electrically coupled to the pair of dipole coils. To transmit data to a magnetic tunnel junction (MTJ) receiver disposed on a second substrate, the drive circuit is configured to drive the pair of dipole coils so as to generate a magnetic field in-plane to the MTJ receiver. Data can be transmitted from the magnetic field-based contactless transmitter to the MTJ receiver using the magnetic field.
    Type: Application
    Filed: September 29, 2016
    Publication date: January 19, 2017
    Inventors: Wenqing Wu, Senthil Kumar Govindaswamy, Raghu Sagar Madala, Peiyuan Wang, Kendrick Hoy Leong Yuen, David Joseph Winston Hansquine
  • Patent number: 9531409
    Abstract: The present disclosure includes switched capacitor transmitter circuits and methods. In one embodiment, the present disclosure includes a plurality of switched capacitor transmitter circuits coupled to inputs of an inductive network. The inductive network combines voltages from the switched capacitor transmitter circuits to produce a combined voltage on an output. In another embodiment, a digital data signal is thermometer encoded and a negative thermo-encoded signal is bit order reversed to control capacitors in a switched capacitor transmitter circuit.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: December 27, 2016
    Assignee: QUALCOMM Incorporated
    Inventors: Daniel Keyes Butterfield, Peiyuan Wang, Jeremy Darren Dunworth
  • Patent number: 9520906
    Abstract: The present disclosure includes switched capacitor transmitter circuits and methods. In one embodiment, a digital data signal is thermometer encoded and a negative thermo-encoded signal is bit order reversed to control capacitors in a switched capacitor transmitter circuit. In another embodiment, the present disclosure includes a plurality of switched capacitor transmitter circuits coupled to inputs of an inductive network. The inductive network combines voltages from the switched capacitor transmitter circuits to produce a combined voltage on an output.
    Type: Grant
    Filed: April 7, 2015
    Date of Patent: December 13, 2016
    Inventors: Daniel Keyes Butterfield, Peiyuan Wang, Jeremy Darren Dunworth
  • Publication number: 20160354400
    Abstract: Disclosed herein are nucleoside phosphoramidates and their use as agents for treating viral diseases. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase, as inhibitors of HCV replication and for treatment of hepatitis C infection in mammals.
    Type: Application
    Filed: February 5, 2016
    Publication date: December 8, 2016
    Inventors: Bruce S. Ross, Michael Joseph Sofia, Ganapati Reddy Pamulapati, Suguna Rachakonda, Hai-Ren Zhang, Byoung-Kwon Chun, Peiyuan Wang
  • Patent number: 9495899
    Abstract: Embodiments described herein are related to contactless data communication. Related systems and methods for contactless data communication are disclosed herein. For example, a magnetic field-based contactless transmitter is disclosed that includes a substrate, a pair of dipole coils disposed on the substrate, and a drive circuit electrically coupled to the pair of dipole coils. To transmit data to a magnetic tunnel junction (MTJ) receiver disposed on a second substrate, the drive circuit is configured to drive the pair of dipole coils so as to generate a magnetic field in-plane to the MTJ receiver. Data can be transmitted from the magnetic field-based contactless transmitter to the MTJ receiver using the magnetic field.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: November 15, 2016
    Assignee: QUALCOMM Incorporated
    Inventors: Wenqing Wu, Senthil Kumar Govindaswamy, Raghu Sagar Madala, Peiyuan Wang, Kendrick Hoy Leong Yuen, David Joseph Winston Hansquine